- Home
- ATHA vs GLBZ Comparison
ATHA vs GLBZ Comparison
Compare ATHA & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- GLBZ
- Stock Information
- Founded
- ATHA 2011
- GLBZ 1949
- Country
- ATHA United States
- GLBZ United States
- Employees
- ATHA N/A
- GLBZ N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- GLBZ Major Banks
- Sector
- ATHA Health Care
- GLBZ Finance
- Exchange
- ATHA Nasdaq
- GLBZ Nasdaq
- Market Cap
- ATHA 14.8M
- GLBZ 12.4M
- IPO Year
- ATHA 2020
- GLBZ N/A
- Fundamental
- Price
- ATHA $0.36
- GLBZ $4.45
- Analyst Decision
- ATHA Hold
- GLBZ
- Analyst Count
- ATHA 3
- GLBZ 0
- Target Price
- ATHA $0.50
- GLBZ N/A
- AVG Volume (30 Days)
- ATHA 149.8K
- GLBZ 6.5K
- Earning Date
- ATHA 11-06-2025
- GLBZ 10-30-2025
- Dividend Yield
- ATHA N/A
- GLBZ N/A
- EPS Growth
- ATHA N/A
- GLBZ N/A
- EPS
- ATHA N/A
- GLBZ 0.01
- Revenue
- ATHA N/A
- GLBZ $12,483,000.00
- Revenue This Year
- ATHA N/A
- GLBZ N/A
- Revenue Next Year
- ATHA N/A
- GLBZ N/A
- P/E Ratio
- ATHA N/A
- GLBZ $422.53
- Revenue Growth
- ATHA N/A
- GLBZ 8.71
- 52 Week Low
- ATHA $0.22
- GLBZ $3.89
- 52 Week High
- ATHA $0.83
- GLBZ $6.99
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- GLBZ 54.41
- Support Level
- ATHA $0.35
- GLBZ $4.32
- Resistance Level
- ATHA $0.40
- GLBZ $4.57
- Average True Range (ATR)
- ATHA 0.02
- GLBZ 0.13
- MACD
- ATHA -0.00
- GLBZ 0.06
- Stochastic Oscillator
- ATHA 11.86
- GLBZ 66.35
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.